Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Lee Jackson | Sep 4, 2013 at 8:25 AM EDT

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive…

Jon C. Ogg | Aug 26, 2013 at 1:29 PM EDT

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Any time you see a merger announcement, you see a myriad of press releases pertaining to law firms and lawyers…

Jon C. Ogg | Aug 26, 2013 at 8:05 AM EDT

Lessons of Buying Growth Companies Doubling Their Revenues

ThinkstockAmgen Inc. (NASDAQ: AMGN) wants to regain its status as the largest publicly traded biotech in the U.S. The company formalized…

Jon C. Ogg | Aug 20, 2013 at 2:57 PM EDT

Medical Marijuana Stock Scam Warning — for Real

ThinkstockIt appears that scam artists are now targeting medical marijuana and legalized marijuana schemes to part you from your money.…

Jon C. Ogg | Aug 12, 2013 at 9:20 AM EDT

Merck Temodar Gets Generic Competition in Brain Cancer

ThinkstockMerck & Co. Inc. (NYSE: MRK) is seeing one more drug drive off the patent cliff. News was released on…

Jon C. Ogg | Aug 12, 2013 at 8:55 AM EDT

Short Interest Declines on Top Health Care Distribution and Technology Stocks to Buy

ThinkstockWhen short interest, or the amount of any specific stock sold short, starts to decline, that is usually a flashing…

Jon C. Ogg | Aug 8, 2013 at 10:50 AM EDT

Opexa Morphs from Mystery Mega-Rally to Money Killer

Opexa Therapeutics Inc. (NASDAQ: OPXA) may have just become the villain of Wall Street in emerging pharma and biotech. This…

Jon C. Ogg | Jul 30, 2013 at 9:45 AM EDT

New State-Sponsored Stem Cell Study Launches for Alzheimer’s Disease

ThinkstockThe war against Alzheimer’s disease is getting another round of stem cell research thrown at it. While this involves a…

Jon C. Ogg | Jul 25, 2013 at 11:30 AM EDT

Sequenom: The Train Wreck Returns

ThinkstockSequenom Inc. (NASDAQ: SQNM) is back in the news, but not in a good way. The company that saw its…

247sam | Jul 24, 2013 at 9:45 AM EDT

Cities Where the Most People Have Heart Attacks

ThinkstockHeart disease, which causes heart attacks, is the leading cause of death in the United States. More than 700,000 Americans…

Jon C. Ogg | Jul 24, 2013 at 8:30 AM EDT

Specialty Pharmaceutical Stocks That May End Up as Takeover Candidates

ThinkstockTypically, specialty pharmaceutical companies either provide generic versions of former top-selling branded drugs or they may focus on drugs that…

Douglas A. McIntyre | Jul 22, 2013 at 10:20 AM EDT

Royal Birth: Likely Corporate Sponsors Look At 240 Million Pound Windfall

ThinkstockThe U.K.’s royal family is wealthy, but likely not wealthy enough to pass up sponsorships as the heir to the…

Paul Ausick | Jul 19, 2013 at 9:55 AM EDT

REIT IPO Prices at Low End of Range

ThinkstockPhysicians Realty Trust (NYSE: DOC) priced its initial public offering (IPO) at $11.50 a share, the low end of the…

Paul Ausick | Jul 17, 2013 at 8:20 AM EDT

Abbott Labs Company Earnings Light on Revenues

ThinkstockAbbott Laboratories (NYSE: ABT) reported second-quarter 2013 results before markets opened this morning. The drugmaker reported adjusted diluted earnings per…

Paul Ausick | Jul 16, 2013 at 9:00 AM EDT

Johnson & Johnson Company Earnings Send Shares to All-Time High

Wikimedia CommonsJohnson & Johnson (NYSE: JNJ) reported second-quarter 2013 results before markets opened this morning. The health care giant reported…

1 … 300 301 302 303 304 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Lessons of Buying Growth Companies Doubling Their Revenues

Medical Marijuana Stock Scam Warning — for Real

Merck Temodar Gets Generic Competition in Brain Cancer

Short Interest Declines on Top Health Care Distribution and Technology Stocks to Buy

Opexa Morphs from Mystery Mega-Rally to Money Killer

New State-Sponsored Stem Cell Study Launches for Alzheimer’s Disease

Sequenom: The Train Wreck Returns

Cities Where the Most People Have Heart Attacks

Specialty Pharmaceutical Stocks That May End Up as Takeover Candidates

Royal Birth: Likely Corporate Sponsors Look At 240 Million Pound Windfall

REIT IPO Prices at Low End of Range

Abbott Labs Company Earnings Light on Revenues

Johnson & Johnson Company Earnings Send Shares to All-Time High

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

Health and Healthcare Articles

All Health and Healthcare Articles

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Lessons of Buying Growth Companies Doubling Their Revenues

Medical Marijuana Stock Scam Warning — for Real

Merck Temodar Gets Generic Competition in Brain Cancer

Short Interest Declines on Top Health Care Distribution and Technology Stocks to Buy

Opexa Morphs from Mystery Mega-Rally to Money Killer

New State-Sponsored Stem Cell Study Launches for Alzheimer’s Disease

Sequenom: The Train Wreck Returns

Cities Where the Most People Have Heart Attacks

Specialty Pharmaceutical Stocks That May End Up as Takeover Candidates

Royal Birth: Likely Corporate Sponsors Look At 240 Million Pound Windfall

REIT IPO Prices at Low End of Range

Abbott Labs Company Earnings Light on Revenues

Johnson & Johnson Company Earnings Send Shares to All-Time High

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Featured Reads

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500